Literature DB >> 27993570

Radiation oncology enters the era of individualised medicine.

Philip Poortmans1, Orit Kaidar-Person2, Paul Span3.   

Abstract

Mesh：

Year:  2016        PMID： 27993570     DOI： 10.1016/S1470-2045(16)30660-X

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  3 in total

1.  Radiosensitivity of Lung Metastases by Primary Histology and Implications for Stereotactic Body Radiation Therapy Using the Genomically Adjusted Radiation Dose.

Authors:  Kamran A Ahmed; Jacob G Scott; John A Arrington; Arash O Naghavi; G Daniel Grass; Bradford A Perez; Jimmy J Caudell; Anders E Berglund; Eric A Welsh; Steven A Eschrich; Thomas J Dilling; Javier F Torres-Roca
Journal:  J Thorac Oncol       Date:  2018-05-05       Impact factor: 20.121

2.  Utilizing the genomically adjusted radiation dose (GARD) to personalize adjuvant radiotherapy in triple negative breast cancer management.

Authors:  Kamran A Ahmed; Casey L Liveringhouse; Matthew N Mills; Nicholas B Figura; G Daniel Grass; Iman R Washington; Eleanor E Harris; Brian J Czerniecki; Peter W Blumencranz; Steven A Eschrich; Jacob G Scott; Roberto Diaz; Javier F Torres-Roca
Journal:  EBioMedicine       Date:  2019-08-12       Impact factor: 11.205

Review 3.  Insights into the theranostic value of precision medicine on advanced radiotherapy to breast cancer.

Authors:  Man Jiang; Jianshe Yang; Kang Li; Jia Liu; Xigang Jing; Meiqin Tang
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.